Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

The symposium highlighted the skin's role in sensing itch, pain, touch, and pleasure, and discussed new research and techniques for understanding and treating these sensations.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

The combination treatment showed a higher response rate but no significant survival benefits.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

The new hydrogel with zinc and polysaccharides improves wound healing and has antibacterial properties.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Peptides from oysters may safely and effectively heal skin wounds with less scarring.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

After a New York Times article talked about using low-dose oral minoxidil for hair loss, more people started getting this drug prescribed, but this trend didn't last long.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.